TEVOGEN BIO HOLDINGS INC (TVGN) Stock Price, Quote, News and Overview
NASDAQ:TVGN - Nasdaq - US88165K1016 - Common Stock - Currency: USD
TVGN Quote, Performance and Key Statistics
1.14
+0.04 (+3.64%)
The current stock price of TVGN is 1.14 USD. In the past month the price decreased by -19.72%. In the past year, price decreased by -83.71%.
TVGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.17 | 378.30B | ||
| AMGN | AMGEN INC | 16.39 | 174.51B | ||
| GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
| ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
| BIIB | BIOGEN INC | 9.13 | 22.01B | ||
| NTRA | NATERA INC | N/A | 19.02B | ||
| GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
Related stock screener links
About TVGN
Company Profile
Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company. The company is headquartered in Warren, New Jersey and currently employs 17 full-time employees. The company went IPO on 2021-11-04. The firm is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, is an off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy designed to fill a critical gap in COVID-19 therapeutic solutions for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of Long COVID. In addition to TVGN 489, it has several product candidates under early-stage development. The firm is developing Epstein-Barr virus (EBV) specific CTLs for potential use in multiple sclerosis (MS) and EBV-associated lymphomas. Its TVGN 601 is being developed for MS, and its TVGN 930 is being developed for EBV-associated lymphomas.
Company Info
TEVOGEN BIO HOLDINGS INC
15 Independence Boulevard, Suite 410
WARREN NEW JERSEY US
Employees: 17
Company Website: https://tevogen.com/
Phone: 16468078832
TEVOGEN BIO HOLDINGS INC / TVGN FAQ
What is the stock price of TEVOGEN BIO HOLDINGS INC today?
The current stock price of TVGN is 1.14 USD. The price increased by 3.64% in the last trading session.
What is the ticker symbol for TEVOGEN BIO HOLDINGS INC stock?
The exchange symbol of TEVOGEN BIO HOLDINGS INC is TVGN and it is listed on the Nasdaq exchange.
On which exchange is TVGN stock listed?
TVGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TEVOGEN BIO HOLDINGS INC stock?
7 analysts have analysed TVGN and the average price target is 4.28 USD. This implies a price increase of 275.79% is expected in the next year compared to the current price of 1.14. Check the TEVOGEN BIO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TEVOGEN BIO HOLDINGS INC worth?
TEVOGEN BIO HOLDINGS INC (TVGN) has a market capitalization of 199.56M USD. This makes TVGN a Micro Cap stock.
How many employees does TEVOGEN BIO HOLDINGS INC have?
TEVOGEN BIO HOLDINGS INC (TVGN) currently has 17 employees.
What are the support and resistance levels for TEVOGEN BIO HOLDINGS INC (TVGN) stock?
TEVOGEN BIO HOLDINGS INC (TVGN) has a support level at 1.1 and a resistance level at 1.29. Check the full technical report for a detailed analysis of TVGN support and resistance levels.
Should I buy TEVOGEN BIO HOLDINGS INC (TVGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TVGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TVGN, evaluating the profitability, health, valuation and growth aspects
- TEVOGEN BIO HOLDINGS INC (TVGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TEVOGEN BIO HOLDINGS INC (TVGN) Sales and EPS estimates to see what analysts future expectations are.
- TEVOGEN BIO HOLDINGS INC (TVGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TEVOGEN BIO HOLDINGS INC (TVGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- TEVOGEN BIO HOLDINGS INC (TVGN) Stock Chart to make your own analysis
- TEVOGEN BIO HOLDINGS INC (TVGN) Latest news and press-releases to stay up to date.
Does TEVOGEN BIO HOLDINGS INC (TVGN) stock pay dividends?
TVGN does not pay a dividend.
What is the Price/Earnings (PE) ratio of TEVOGEN BIO HOLDINGS INC (TVGN)?
The PE ratio for TEVOGEN BIO HOLDINGS INC (TVGN) is 3. This is based on the reported non-GAAP earnings per share of 0.38 and the current share price of 1.14 USD. Check the full fundamental report for a full analysis of the valuation metrics for TVGN.
What is the Short Interest ratio of TEVOGEN BIO HOLDINGS INC (TVGN) stock?
The outstanding short interest for TEVOGEN BIO HOLDINGS INC (TVGN) is 10.27% of its float. Check the ownership tab for more information on the TVGN short interest.
TVGN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to TVGN. When comparing the yearly performance of all stocks, TVGN is a bad performer in the overall market: 91.9% of all stocks are doing better.
TVGN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TVGN. Both the profitability and financial health of TVGN have multiple concerns.
TVGN Financial Highlights
Over the last trailing twelve months TVGN reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS increased by 375% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 337.72% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TVGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to TVGN. The Buy consensus is the average rating of analysts ratings from 7 analysts.